Cerevel Therapeutics Hldng I shares owned by Barclays
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $16M | 378k | 42.40 |
| 2023-09-30 | $3.2M | 146k | 21.83 |
| 2023-06-30 | $4.2M | 131k | 31.79 |
| 2023-03-31 | $15M | 601k | 24.39 |
| 2022-12-31 | $14M | 457k | 31.54 |
| 2022-09-30 | $2.8M | 98k | 28.26 |
| 2022-06-30 | $74k | 2.8k | 26.42 |
| 2022-03-31 | $239k | 6.8k | 35.06 |